B. Shea

发表

Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trials

P. Tugwell, V. Welch, J. Jull, 2015, Implementation Science.

Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritis.

P. Tugwell, V. Welch, B. Shea, 2005, The Cochrane database of systematic reviews.

The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses

P. Tugwell, B. Shea, Dianne O'Connell, 2014 .

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

M. Hernán, P. Santaguida, P. Tugwell, 2016, British Medical Journal.

Minimal clinically important differences: review of methods.

B Shea, P Tugwell, P. Tugwell, 2001, The Journal of rheumatology.

PROTOCOL: Health, social care and technological interventions to improve functional ability of older adults: Evidence and gap map

R. Sadana, E. Kristjansson, K. Pottie, 2019, Campbell Systematic Reviews.

GRADE Equity Guidelines 4 : Guidance on how to asses s and address health equity within the evidence to decision process Paper Type :

G. Guyatt, P. Tugwell, V. Welch, 2017 .

Fluoride for the Treatment of Postmenopausal Osteoporotic Fractures: A Meta-Analysis

P. Tugwell, V. Welch, B. Shea, 2000, Osteoporosis International.

Prazosin for Raynaud's phenomenon in progressive systemic sclerosis.

A. Silman, B. Shea, D. Furst, 1998, The Cochrane database of systematic reviews.

Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis.

V. Welch, B. Shea, B. Shea, 2001, Arthritis and rheumatism.

Patient preferences to value health outcomes in rheumatology clinical trials: Report from the OMERACT special interest group✰.

P. Tugwell, B. Shea, M. Hiligsmann, 2021, Seminars in arthritis and rheumatism.

Responsiveness of endpoints in osteoporosis clinical trials--an update.

P. Tugwell, V. Welch, J. McGowan, 1999, The Journal of rheumatology.

Alendronate for osteoporosis in postmenopausal women

G. Guyatt, P. Tugwell, B. Shea, 1998 .

Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients

G. Guyatt, B. Shea, P. Glasziou, 2015, BMJ : British Medical Journal.

Towards a definition of "difference" in osteoarthritis.

M. Dougados, B. Shea, G. Wells, 2001, The Journal of rheumatology.

Cigarette smoking and peripheral arterial occlusive disease.

D. Moher, B. Shea, C. W. Cole, 1993, Surgery.

Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach.

Linda C. Li, M. Suarez‐Almazor, P. Tugwell, 2021, Seminars in arthritis and rheumatism.

Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis.

A. Silman, B. Shea, D. Furst, 1998, The Cochrane database of systematic reviews.

Calcium and vitamin D for corticosteroid-induced osteoporosis.

M. Suarez‐Almazor, P. Tugwell, B. Shea, 1998, The Cochrane database of systematic reviews.

Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosis.

A. Silman, B. Shea, D. Furst, 1998, The Cochrane database of systematic reviews.

Pharmacotherapy for Behcet's syndrome.

P. Tugwell, V. Welch, B. Shea, 1998, The Cochrane database of systematic reviews.

Discrimination of changes in osteoporosis outcomes.

P. Tugwell, V. Welch, B. Shea, 2001, The Journal of rheumatology.

Low level laser therapy (classes I, II and III) for the treatment of osteoarthritis.

P. Tugwell, V. Welch, B. Shea, 2000, The Cochrane database of systematic reviews.

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

B. Shea, M. D. de Wit, W. Campbell, 2016, Annals of the rheumatic diseases.

OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods study.

P. Tugwell, B. Shea, M. D. de Wit, 2021, Seminars in arthritis and rheumatism.

Minimal clinically important difference module: summary, recommendations, and research agenda.

P. Tugwell, C. Bombardier, M. Dougados, 2001, The Journal of rheumatology.

The ASAS-OMERACT core domain set for axial spondyloarthritis.

M. Dougados, B. Shea, A. Boonen, 2021, Seminars in arthritis and rheumatism.

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016

B. Shea, M. D. de Wit, W. Campbell, 2017, The Journal of Rheumatology.

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials

P. Tugwell, B. Shea, M. D. de Wit, 2019, The Journal of Rheumatology.

A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis.

M. Suarez‐Almazor, P. Tugwell, B. Shea, 1999, The Journal of rheumatology.

Low level laser therapy (Classes I, II and III) for treating osteoarthritis.

P. Tugwell, V. Welch, B. Shea, 2004, The Cochrane database of systematic reviews.

Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis.

M. Suarez‐Almazor, P. Tugwell, V. Welch, 2000, The Cochrane database of systematic reviews.

Endorsement of the domains of knee and hip osteoarthritis (OA) flare: A report from the OMERACT 2020 inaugural virtual consensus vote from the flares in OA working group.

Win Min Oo, Linda C. Li, B. Shea, 2021, Seminars in arthritis and rheumatism.

OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies

B. Shea, Yeong-Wook Song, J. Park, 2019, The Journal of Rheumatology.

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials

P. Tugwell, B. Shea, M. D. de Wit, 2018, The Journal of Rheumatology.

The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials.

P. Tugwell, P. Tugwell, B. Shea, 1999, The Journal of rheumatology.

Low level laser therapy (classes I, II and III) in the treatment of rheumatoid arthritis.

P. Tugwell, V. Welch, B. Shea, 2000, The Cochrane database of systematic reviews.

WITHDRAWN: Low level laser therapy (Classes III) for treating osteoarthritis.

P. Tugwell, B. Shea, G. Wells, 2007, The Cochrane database of systematic reviews.

A Meta-analysis of Etidronate for the Treatment of Postmenopausal Osteoporosis

G. Guyatt, P. Tugwell, V. Welch, 2001, Osteoporosis International.

Health, social care and technological interventions to improve functional ability of older adults living at home: An evidence and gap map

R. Sadana, V. Welch, E. Kristjansson, 2021, Campbell systematic reviews.

Fluoride for treating postmenopausal osteoporosis.

P. Tugwell, V. Welch, B. Shea, 2000, The Cochrane database of systematic reviews.

Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip.

B. Shea, M. Hochberg, G. Wells, 2006, The Cochrane database of systematic reviews.

Transcutaneous electrical nerve stimulation for knee osteoarthritis.

P. Tugwell, V. Welch, J. McGowan, 2000, The Cochrane database of systematic reviews.

Transcutaneous electrical nerve stimulation (TENS) for chronic low-back pain.

P. Tugwell, B. Shea, G. Wells, 2005, The Cochrane database of systematic reviews.

Do silicone breast implants cause rheumatologic disorders? A systematic review for a court-appointed national science panel.

P. Tugwell, V. Welch, J. McGowan, 2001, Arthritis and rheumatism.

Osteoporosis clinical trials endpoints: candidate variables and clinimetric properties.

A. Silman, S. Cummings, P. Tugwell, 1997, The Journal of rheumatology.

Calcium supplementation on bone loss in postmenopausal women.

G. Guyatt, P. Tugwell, B. Shea, 2006, The Cochrane database of systematic reviews.

Exercise for preventing and treating osteoporosis in postmenopausal women.

P. Tugwell, B. Shea, S. Negrini, 2011, The Cochrane database of systematic reviews.

When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework

C Weijer, M Taljaard, B Shea, 2017, BMJ Open.

Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis

M. Suarez‐Almazor, P. Tugwell, B. Shea, 2019, The Journal of Rheumatology.

Therapeutic ultrasound for osteoarthritis of the knee.

P. Tugwell, V. Welch, B. Shea, 2001, Cochrane Database of Systematic Reviews.

Core Set of Domains for Outcome Measures in Behçet's Syndrome

P. Tugwell, B. Shea, P. Merkel, 2020, Arthritis care & research.

Individualized functional priority approach to the assessment of health related quality of life in rheumatology.

P. Tugwell, P. Tugwell, B. Shea, 2001, The Journal of rheumatology.

Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.

C. Bombardier, B. Shea, G. Wells, 2001, The Journal of rheumatology.

Injectable gold for rheumatoid arthritis.

M. Suarez‐Almazor, P. Tugwell, C. Bombardier, 1997, The Cochrane database of systematic reviews.

Low level laser therapy for osteoarthritis and rheumatoid arthritis: a metaanalysis.

P. Tugwell, P. Tugwell, V. Welch, 2000, The Journal of rheumatology.

Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis.

A. Silman, B. Shea, D. Furst, 1998, The Cochrane database of systematic reviews.

Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting

B. Shea, M. D. de Wit, L. Coates, 2018, Journal of Rheumatology Supplement.

Methodological quality of systematic reviews in subfertility: a comparison of Cochrane and non-Cochrane systematic reviews in assisted reproductive technologies.

B. Shea, C. Farquhar, M. Showell, 2012, Human reproduction.

Moving Towards Common Data Elements and Core Outcome Measures in Frailty Research

P. Tugwell, B. Shea, J. Lynn, 2019, The Journal of Frailty & Aging.

Systematically reviewing qualitative studies complements survey design: an exploratory study of barriers to paediatric immunisations.

G. Guyatt, B. Shea, K. Wilson, 2005, Journal of clinical epidemiology.

Evidence for Psoriatic Arthritis Impact of Disease (PsAID12) as Core Instrument to Measure Health-Related Quality of Life in Psoriatic Arthritis: A Systematic Review of Psychometric Properties

P. Tugwell, B. Shea, M. D. de Wit, 2019 .

The 66/68 Joint Count for the Measurement of MSK Disease Activity/Peripheral Joint Activity in Psa: A Grappa-Omeract Working Group Initiative

B. Shea, L. Coates, D. Gladman, 2018 .

WITHDRAWN: Etidronate for treating and preventing postmenopausal osteoporosis.

G. Guyatt, B. Shea, L. Griffith, 2007, The Cochrane database of systematic reviews.

Etidronate for treating and preventing postmenopausal osteoporosis.

G. Guyatt, P. Tugwell, V. Welch, 2001, The Cochrane database of systematic reviews.

GRADE equity guidelines 4: considering health equity in GRADE guideline development: evidence to decision process.

Matthias Briel, Elie A Akl, Jasvinder Singh, 2017, Journal of clinical epidemiology.

GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence

Matthias Briel, Robin Christensen, Monica Hultcrantz, 2017, Journal of clinical epidemiology.

Considering health equity when moving from evidence-based guideline recommendations to implementation: a case study from an uppermiddle income country on the GRADE approach.

G. Guyatt, P. Tugwell, V. Welch, 2017, Health policy and planning.

Is health equity considered in systematic reviews of the Cochrane Musculoskeletal Group?

M. Suarez‐Almazor, P. Tugwell, V. Welch, 2008, Arthritis and rheumatism.

Moderate-term, low-dose corticosteroids for rheumatoid arthritis.

M. Suarez‐Almazor, V. Welch, B. Shea, 1998, The Cochrane database of systematic reviews.

Transcutaneous electrical nerve stimulation (TENS) for chronic low-back pain (Review)

P. Tugwell, B. Shea, G. Wells, 2008 .

Transcutaneous electrical nerve stimulation (TENS) for chronic low back pain.

P. Tugwell, V. Welch, B. Shea, 2005, Cochrane Database of Systematic Reviews.

WITHDRAWN: Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip.

B. Shea, M. Hochberg, G. Wells, 2007, The Cochrane database of systematic reviews.

Improving social justice in observational studies: protocol for the development of a global and Indigenous STROBE-equity reporting guideline

A. Dicko, J. Jull, J. Petkovic, 2023, International Journal for Equity in Health.

SAT0395 RESPONSIVENESS AND CLINICAL TRIAL DISCRIMINATION OF SWOLLEN AND TENDER JOINT COUNTS FOR THE MEASUREMENT OF MSK DISEASE ACTIVITY IN PSORIATIC ARTHRITIS

B. Shea, L. Coates, D. Gladman, 2019, Saturday, 15 June 2019.

Cochrane Review on exercise for preventing and treating osteoporosis in postmenopausal women.

P. Tugwell, B. Shea, S. Negrini, 2004, Europa medicophysica.

Calcium supplementation on bone loss in postmenopausal women.

G. Guyatt, P. Tugwell, B. Shea, 2007, The Cochrane database of systematic reviews.

Therapeutic ultrasound for treating patellofemoral pain syndrome.

P. Tugwell, B. Shea, G. Wells, 2001, The Cochrane database of systematic reviews.

Risedronate for the prevention and treatment of postmenopausal osteoporosis.

G. Guyatt, P. Tugwell, B. Shea, 2003, The Cochrane database of systematic reviews.

Deep transverse friction massage for treating tendinitis.

P. Tugwell, B. Shea, G. Wells, 2002, The Cochrane database of systematic reviews.

Reporting of sex and gender in randomized controlled trials in Canada: a cross-sectional methods study

V. Welch, J. Jull, J. Petkovic, 2017, Research Integrity and Peer Review.

Considering health equity when moving from evidence-based guideline recommendations to implementation: a case study from an upper-middle income country on the GRADE approach

G. Guyatt, P. Tugwell, V. Welch, 2017, Health policy and planning.

WITHDRAWN: Risedronate for the prevention and treatment of postmenopausal osteoporosis.

G. Guyatt, P. Tugwell, B. Shea, 2007, The Cochrane database of systematic reviews.

Responsiveness of endpoints in osteoporosis clinical trials.

P. Tugwell, B. Shea, G. Wells, 1997, The Journal of rheumatology.

Implications of OMERACT outcomes in arthritis and osteoporosis for cochrane metaanalysis.

P. Tugwell, B. Shea, G. Wells, 1997, The Journal of rheumatology.

Atherosclerotic risk factors in abdominal aortic aneurysm and peripheral vascular occlusive disease

D. Moher, B. Shea, G. Hill, 1994 .

OMERACT 2020: A virtual (R)evolution.

P. Tugwell, B. Shea, J. Singh, 2021, Seminars in arthritis and rheumatism.

Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients

G. Guyatt, B. Shea, P. Glasziou, 2015, British medical journal.

Guidelines for Laboratory Evaluation in the Diagnosis of Lyme Disease

P. Tugwell, B. Shea, A. Steere, 1997, Annals of Internal Medicine.

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016

B. Shea, M. D. de Wit, L. Coates, 2017, The Journal of Rheumatology.

GRADE equity guidelines 4: considering health equity in GRADE guideline development: evidence to decision process.

G. Guyatt, P. Tugwell, V. Welch, 2017, Journal of clinical epidemiology.

a tool for assessing risk of bias in non-randomized studies

M. Hernán, P. Santaguida, J. Sterne, 2016 .

Methodological Quality of Systematic Reviews in Subfertility: A Comparison of Two Different Approaches

B. Shea, C. Farquhar, M. Showell, 2012, PloS one.